Posted on 25/01/2010 in Medical Company Financials Kimberly-Clark this week published its financial results for 2009 and revealed further information about its outlook for 2010.
Sales during the fourth quarter of 2009 increased by 8.4 per cent to $5.0 billion (3.09 billion pounds), the firm revealed.
Additionally, organic sales rose by almost three per cent, something it believes was accelerated by higher sales volumes of approximately two per cent, as well as higher net selling prices.
For the full year 2009, diluted net income per share was $4.52, compared to the organisation's predicted sum of $4.50 to $4.60.
Chairman and chief executive officer of the firm Thomas Falk said that the group's achievements in 2009 were at the "high-end" of its targets for the future.
He furthered: "In 2009, we delivered [an] excellent performance in the near term, while we maintained our strong focus on doing what's right for sustainable, long-term growth."
In September, Kimberly-Clark revealed the recruitment of a new vice-president, Kim Underhill, following the departure of Giles Turrell. Other news stories from 25/01/2010
Read more in the Zenopa News Archive
How this news is generated
|
